Search

everythinglearnresearchcommunity

for

Search:↓

Hormone imbalances can cause specific skin changes, which may help in early detection of endocrine disorders.

Melatonin improved mental health and metabolism in women with PCOS.

Hormones might affect the skin condition hidradenitis suppurativa, but their exact role is unclear.

Testosterone therapy is generally safe for transmen, improves sexual function, and has manageable health risks with proper monitoring.

Women with PCOS are more likely to have fatty liver disease, especially if they have metabolic problems.

To diagnose Polycystic Ovarian Syndrome, two out of three signs—irregular periods, high male hormone levels, or cysts on the ovaries—are needed.

Intense pulsed light (IPL) is an efficient and safe method for hair removal, reducing hair by about 80%.

Gonadal dysgenesis, like Turner's and Klinefelter's syndromes, negatively affects bone health, but hormone treatments can help.

Finasteride 5 mg/day effectively treats hair loss in postmenopausal women without hyper-androgenism.

Accurate diagnosis is key for treating different kinds of hair loss, and immune response variations may affect the condition and treatment results.

FAGA diagnosis uses blood tests and trichoscopy, with treatments like topical minoxidil, oral anti-androgens, and hormone-modulating drugs.

Hormonal therapies are safe and effective for treating adult women's acne.

Cyproterone acetate is effective for treating hirsutism and acne but less so for hair loss, with side effects similar to birth control pills.

Antiandrogen therapy helped increase hair growth in women with hormonal imbalances related to baldness.

Adult female acne requires a comprehensive treatment approach, including medical options and lifestyle changes, with attention to psychological well-being.

Women with PCOS are more likely to have insulin resistance and obesity, especially those with the most severe type I PCOS.

The conclusion is that oral contraceptives and antiandrogens can treat hirsutism and acne in women with cutaneous hyperandrogenism, but more research is needed for effective treatments, especially for hair loss.

Hair growth is influenced by various body and external factors, and neighboring hairs communicate to synchronize regeneration.

The research found that polycystic ovary syndrome (PCOS) has two distinct types, with one having more severe hormone and insulin issues.

The conclusion is that we need more effective hair loss treatments than the current ones, and these could include new drugs, gene and stem cell therapy, hormones, and scalp cooling, but they all need thorough safety testing.

The document concludes that correct diagnosis and management of PCOS are important, and more research is needed on its risks and treatments.

Excessive hair growth can be assessed by history, exam, and blood tests, and treated with medication like dexamethasone, birth control pills, and spironolactone.

Different hair protein amounts change the strength of keratin/chitosan gels, useful for making predictable tissue engineering materials.

Hidradenitis suppurativa may be related to hormones and patients often have metabolic disorders; more research is needed to understand this connection.

The conclusion is that hirsutism should be diagnosed and treated because it affects quality of life and may signal other health problems.

Blocking JAK/STAT pathways can help treat hair loss from alopecia areata.

JAK inhibitors show promise for treating skin and hair disorders but need more research on long-term safety and effectiveness.

The French Endocrine Society suggests diagnosing PCOS with two of three signs, recommends lifestyle changes and clomiphene for treatment, and calls for more research on certain treatments and tests.

AGA patients have fewer hairs and smaller follicles; T:V ratio above 4:1 may indicate AGA.

Metformin and rosiglitazone both improved insulin use and hormonal symptoms in women with PCOS.